Literature DB >> 15381127

Biogenerics: Europe takes another step forward while the FDA dives for cover.

Paul Chamberlain.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15381127     DOI： 10.1016/S1359-6446(04)03215-5

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN： 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  2 in total

1.  Generic biopharmaceutical drugs: an economic and policy analysis.

Authors:  Erwin A Blackstone; Joseph P Fuhr
Journal:  Biotechnol Healthc       Date:  2007-02

2.  Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.

Authors:  Jorge F Pérez-Oliva; Martha Casanova-González; Idrian García-García; Pedro J Porrero-Martín; Carmen M Valenzuela-Silva; Tairí Hernández-Montero; Marcia Lagarde-Ampudia; Yuri Casanova-Kutsareva; Yisel Avila-Albuerne; Alicia Vargas-Batista; Hailen Bobillo-López; Raúl Herrera-Valdés; Pedro A López-Saura
Journal:  BMC Nephrol       Date:  2005-05-23       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.